Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Healthtrust
Chinese Patent Office
Moodys
Julphar
QuintilesIMS
UBS
Accenture
Fuji

Generated: April 20, 2018

DrugPatentWatch Database Preview

TACARYL Drug Profile

« Back to Dashboard

When do Tacaryl patents expire, and what generic alternatives are available?

Tacaryl is a drug marketed by Westwood Squibb and is included in one NDA.

The generic ingredient in TACARYL is methdilazine. There are four drug master file entries for this compound. Additional details are available on the methdilazine profile page.
Drug patent expirations by year for TACARYL
Synonyms for TACARYL
10-((1-methyl-3-pyrrolidinyl)methyl)-10H-phenothiazine
10-((1-Methyl-3-pyrrolidinyl)methyl)phenothiazine
10-[(1-Methyl-3-pyrrolidinyl)methyl]-10H-phenothiazine #
10-[(1-Methyl-3-Pyrrolidinyl)methyl]phenothiazine
10-[(1-methylpyrrolidin-3-yl)methyl]-10H-phenothiazine
10-[(1-Methylpyrrolidin-3-yl)methyl]phenothiazine
10H-Phenothiazine, 10-((1-methyl-3-pyrrolidinyl)methyl)-
10H-Phenothiazine, 10-[(1-methyl-3-pyrrolidinyl)methyl]-
10H-Phenothiazine, tannate (5:1)
1229-35-2 (hydrochloride)
1982-37-2
3B1-002759
AC1L24C6
AC1Q7G4W
BDBM81470
C07175
C18H20N2S
CAS_14677
CHEBI:6823
CHEMBL1200959
D04979
D0LR0R
DB00902
Dilosyn (Salt/Mix)
Disyncram
Disyncram (Salt/Mix)
Disyncran (Salt/Mix)
DTXSID6023282
EINECS 217-841-6
GTPL7231
HTMIBDQKFHUPSX-UHFFFAOYSA-N
L001130
LS-979
METHDILAZINE
Methdilazine (INN)
Methdilazine [USAN:INN:BAN]
Methdilazine [USP:INN:BAN]
Methdilazinum
Methdilazinum [INN-Latin]
Methilazine hydrochloride
Methodilazine
Metodilazina
Metodilazina [INN-Spanish]
NCI-C60720
NCI60_001351
NSC_14677
NSC-244191
NSC169091
NSC244191
PDSP1_000149
PDSP2_000148
Phenothiazine, 10-((1-methyl-3-pyrrolidinyl)methyl)-
Phenothiazine, 10-[(1-methyl-3-pyrrolidinyl)methyl]-
PL005357
PL049705
Product 5022
SCHEMBL121507
SR-01000944494
SR-01000944494-1
Tacaryl (TN)
Tacazyl
Tacryl

US Patents and Regulatory Information for TACARYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Westwood Squibb TACARYL methdilazine hydrochloride SYRUP;ORAL 011950-007 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Westwood Squibb TACARYL methdilazine TABLET, CHEWABLE;ORAL 011950-009 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Westwood Squibb TACARYL methdilazine hydrochloride TABLET;ORAL 011950-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Cantor Fitzgerald
Covington
Queensland Health
QuintilesIMS
Daiichi Sankyo
Mallinckrodt
Citi
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.